DLA Piper advises Haemonetics in its acquisition of Attune Medical for US$160 million

DLA Piper represented Haemonetics Corporation (Haemonetics), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, in its acquisition of Chicago-based Attune Medical, manufacturer of the ensoETM® proactive esophageal cooling device, for an upfront cash payment of US$160 million at closing plus additional contingent consideration.

The acquisition is subject to customary closing conditions and is expected to be completed in the first quarter of Haemonetics' fiscal year 2025.

The DLA Piper team representing Haemonetics was led by partner Adam Ghander (Boston) and includes partner Kurt Weaver (Boston), of counsels Nia Brown (Washington, DC) and Crystal Woods (Dallas), and associate Michael Jamieson (Boston) and attorney Eran Hingaly (Boston).

With more than 1,000 corporate lawyers globally, DLA Piper helps clients execute complex transactions seamlessly while supporting clients across all stages of development. The firm has been rated number one in global M&A volume for 15 consecutive years, according to Mergermarket, and ranked as a top five most active VC legal advisor in the US and number one in VC, PE and M&A in combined global deal volume according to PitchBook.